Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 4
2006 8
2007 3
2008 4
2009 2
2010 3
2011 1
2016 1
2017 4
2018 1
2019 2
2020 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
Tsubouchi K, Hamada N, Tokunaga S, Ichiki K, Takata S, Ishii H, Kitasato Y, Okamoto M, Kawakami S, Yatera K, Kawasaki M, Fujita M, Yoshida M, Maeyama T, Harada T, Wataya H, Torii R, Komori M, Mizuta Y, Tobino K, Harada E, Yabuuchi H, Nakanishi Y, Okamoto I. Tsubouchi K, et al. Among authors: wataya h. BMJ Open Respir Res. 2023 Nov;10(1):e001864. doi: 10.1136/bmjresp-2023-001864. BMJ Open Respir Res. 2023. PMID: 37963676 Free PMC article.
Immune checkpoint protein and cytokine expression by T lymphocytes in pleural effusion of cancer patients receiving anti-PD-1 therapy.
Ikematsu Y, Tanaka K, Yanagihara T, Liu R, Inoue H, Yoneshima Y, Ota K, Iwama E, Takata S, Hata K, Takahata Y, Wataya H, Nakanishi Y, Okamoto I. Ikematsu Y, et al. Among authors: wataya h. Lung Cancer. 2019 Dec;138:58-64. doi: 10.1016/j.lungcan.2019.10.011. Epub 2019 Oct 13. Lung Cancer. 2019. PMID: 31639551 Free article.
Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801.
Takayama K, Takeshita M, Inoue K, Ichiki M, Fujita M, Harada T, Shiraishi Y, Wataya H, Tokunaga S, Yamada T, Uchino J, Sugio K. Takayama K, et al. Among authors: wataya h. Oncologist. 2020 Aug;25(8):e1146-e1157. doi: 10.1634/theoncologist.2020-0322. Epub 2020 May 18. Oncologist. 2020. PMID: 32385918 Free PMC article. Clinical Trial.
Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer.
Fujita M, Ouchi H, Inoue Y, Inoshima I, Ohshima T, Yoshimura C, Wataya H, Kawasaki M, Tokunaga S, Nakanishi Y; Lung Oncology Group in Kyushu (LOGIK). Fujita M, et al. Among authors: wataya h. J Infect Chemother. 2010 Apr;16(2):113-7. doi: 10.1007/s10156-010-0030-3. Epub 2010 Feb 4. J Infect Chemother. 2010. PMID: 20130951 Clinical Trial.
The efficacy and safety of cefepime or meropenem in the treatment of febrile neutropenia in patients with lung cancer. A randomized phase II study.
Fujita M, Matsumoto T, Inoue Y, Wataya H, Takayama K, Ishida M, Ebi N, Kishimoto J, Ichinose Y; Lung Oncology Group in Kyushu (LOGIK). Fujita M, et al. Among authors: wataya h. J Infect Chemother. 2016 Apr;22(4):235-9. doi: 10.1016/j.jiac.2016.01.005. Epub 2016 Feb 8. J Infect Chemother. 2016. PMID: 26867793 Clinical Trial.
37 results